Evidence map›Paper›PMID 32354205›Full record

ArticleInternational journal of molecular sciences2020

Role of

Chang-Kyu Oh, Ji Wan Kang, Yoonsung Lee, Kyungjae Myung, Mihyang Ha, Junho Kang, Eun Jung Kwon, Youngjoo Kim, Sae-Ock Oh, Hye Jin Heo and 2 more

Open access · goldAbstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Chang-Kyu OhCenter for Genomic Integrity, Institute for Basic Science (IBS), Ulsan 44919, Korea.
Ji Wan KangInterdisciplinary program of genomic science, Pusan National University, Yangsan 50612, Korea.
Yoonsung LeeCenter for Genomic Integrity, Institute for Basic Science (IBS), Ulsan 44919, Korea.
Kyungjae MyungCenter for Genomic Integrity, Institute for Basic Science (IBS), Ulsan 44919, Korea.
Mihyang HaInterdisciplinary program of genomic science, Pusan National University, Yangsan 50612, Korea.
Junho KangInterdisciplinary program of genomic science, Pusan National University, Yangsan 50612, Korea.
Eun Jung KwonInterdisciplinary program of genomic science, Pusan National University, Yangsan 50612, Korea.
Youngjoo KimInterdisciplinary program of genomic science, Pusan National University, Yangsan 50612, Korea.
Sae-Ock OhDepartment of Anatomy, School of Medicine, Pusan National University, Yangsan 50612, Korea.
Hye Jin HeoDepartment of Anatomy, School of Medicine, Pusan National University, Yangsan 50612, Korea.
Shin KimDepartment of Immunology, School of Medicine, Keimyung University, Dalseo-gu, Daegu 42601, Korea.
Yun Hak KimDepartment of Anatomy, School of Medicine, Pusan National University, Yangsan 50612, Korea.
Pusan National University · KRInstitute for Basic Science · KR

Funding

Institute for Basic Science 2014R1A5A2010008National Research Foundation of Korea 2018R1A5A2023879National Research Foundation of Korea 2019R1A2B5B01070163
6 · The paper itself

Abstract

Relapse of acute lymphoblastic leukemia (ALL) is dangerous and it worsens the prognosis of patients; however, prognostic markers or therapeutic targets for ALL remain unknown. In the present study, using databases such as TARGET, GSE60926 and GSE28460, we determined that

Indexed as

Amino Acid SequenceAnimalsBiomarkers, TumorConserved SequenceDatabases, GeneticFemaleGene Expression Regulation, DevelopmentalGene Expression Regulation, NeoplasticHematopoiesisHumansKinesinsMaleNeoplasm Recurrence, LocalPrecursor Cell Lymphoblastic Leukemia-LymphomaProtein DomainsUp-RegulationBiomarkers, TumorKIF18B protein, humanKIF2C protein, humanKinesinsZebrafish ProteinsALLGEOhematopoiesisKIF2CTARGETzebrafish

Identifiers

PMID32354205
PMCPMC7246619
OpenAlexW3023854765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.